Apellis Pharmaceuticals Inc (APLS) — Cash Flow Reinvestment Rate
Apellis Pharmaceuticals Inc (APLS) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $296.00K (capex $148.00K plus investments $-148.00K) from operating cash flow of $108.47 Million. See Apellis Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Apellis Pharmaceuticals Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Apellis Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Apellis Pharmaceuticals Inc (APLS) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Apellis Pharmaceuticals Inc (2025–2025)
Year-by-year capital reinvestment analysis for Apellis Pharmaceuticals Inc. See financial flexibility index of Apellis Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | $313.00K | $45.33 Million | $313.00K | — |